EJNMMI - European Journal of Nuclear Medicine and Molecular Imaging

Vol. 44 Number 11

View Issue

Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?
Author(s): David Groheux; Elif Hindié

Pages: 1571 - 1573
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
Author(s): Su Hyun Lee; Seunggyun Ha; Hyun Joon An; Jae Sung Lee; Wonshik Han; Seock-Ah Im; Han Suk Ryu; Won Hwa Kim; Jung Min Chang; Nariya Cho; Woo Kyung Moon; Gi Jeong Cheon

Pages: 1574 - 1584
Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
Author(s): Bernhard Nilica; Dietmar Waitz; Vlado Stevanovic; Christian Uprimny; Dorota Kendler; Sabine Buxbaum; Boris Warwitz; Llanos Gerardo; Benjamin Henninger; Irene Virgolini; Margarida Rodrigues

Pages: 1585 - 1592
Role of 68Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
Author(s): Vikas Prasad; Aurora Sainz-Esteban; Ruza Arsenic; Ursula Plöckinger; Timm Denecke; Ulrich-Frank Pape; Andreas Pascher; Peter Kühnen; Marianne Pavel; Oliver Blankenstein

Pages: 1593 - 1600
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
Author(s): Cristina Nanni; Lucia Zanoni; Cristian Pultrone; Riccardo Schiavina; Eugenio Brunocilla; Filippo Lodi; Claudio Malizia; Matteo Ferrari; Patrizio Rigatti; Cristina Fonti; Giuseppe Martorana; Stefano Fanti

Pages: 1601 - 1610
Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
Author(s): Ali Afshar-Oromieh; Henrik Hetzheim; Wolfgang Kübler; Clemens Kratochwil; Frederik L. Giesel; Thomas A. Hope; Matthias Eder; Michael Eisenhut; Klaus Kopka; Uwe Haberkorn

Pages: 1611 - 1620
RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study
Author(s): Shih-Hsin Chen; Hung-Ming Wang; Chien-Yu Lin; Joseph Tung-Chieh Chang; Chia-Hsun Hsieh; Chun-Ta Liao; Chung-Jan Kang; Lan-Yan Yang; Tzu-Chen Yen

Pages: 1621 - 1629
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei
Author(s): Julien Dubreuil; Francesco Giammarile; Pascal Rousset; Naoual Bakrin; Guillaume Passot; Sylvie Isaac; Olivier Glehen; Andrea Skanjeti

Pages: 1630 - 1637
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study
Author(s): Seung Hyup Hyun; Jae Seon Eo; Jeong Won Lee; Joon Young Choi; Kyung-Han Lee; Sae Jung Na; Il Ki Hong; Jin Kyoung Oh; Yong An Chung; Bong-Il Song; Tae-Sung Kim; Kyung Sik Kim; Dae Hyuk Moon; Mijin Yun

Pages: 1638 - 1645
18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease
Author(s): Verena Ruhlmann; Thorsten Dirk Poeppel; Alexander Sascha Brandt; Johannes Grüneisen; Marcus Ruhlmann; Jens Matthias Theysohn; Michael Forsting; Andreas Bockisch; Lale Umutlu

Pages: 1646 - 1652
[11C]TASP457, a novel PET ligand for histamine H3 receptors in human brain
Author(s): Yasuyuki Kimura; Chie Seki; Yoko Ikoma; Masanori Ichise; Kazunori Kawamura; Keisuke Takahata; Sho Moriguchi; Tomohisa Nagashima; Tatsuya Ishii; Soichiro Kitamura; Fumitoshi Niwa; Hironobu Endo; Makiko Yamada; Makoto Higuchi; Ming-Rong Zhang; Tetsuya Suhara

Pages: 1653 - 1663
Ability of 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI to assess striatal involvement in paediatric glioma
Author(s): Giovanni Morana; Matteo Puntoni; Maria Luisa Garrè; Michela Massollo; Egesta Lopci; Merhdad Naseri; Mariasavina Severino; Domenico Tortora; Andrea Rossi; Arnoldo Piccardo

Pages: 1664 - 1672
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers
Author(s): Philip J. O’Halloran; Thomas Viel; David W. Murray; Lydia Wachsmuth; Katrin Schwegmann; Stefan Wagner; Klaus Kopka; Monika A. Jarzabek; Patrick Dicker; Sven Hermann; Cornelius Faber; Tim Klasen; Michael Schäfers; David O’Brien; Jochen H. M. Prehn; Andreas H. Jacobs; Annette T. Byrne

Pages: 1673 - 1683
Tau PET and tauopathies
Author(s): Karl Herholz

Pages: 1684 - 1685
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Author(s): Konstantinos Chiotis; Laure Saint-Aubert; Irina Savitcheva; Vesna Jelic; Pia Andersen; My Jonasson; Jonas Eriksson; Mark Lubberink; Ove Almkvist; Anders Wall; Gunnar Antoni; Agneta Nordberg

Pages: 1686 - 1699
Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease
Author(s): Solveig Tiepolt; Swen Hesse; Marianne Patt; Julia Luthardt; Matthias L. Schroeter; Karl-Titus Hoffmann; David Weise; Hermann-Josef Gertz; Osama Sabri; Henryk Barthel

Pages: 1700 - 1709
In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid
Author(s): J. L. Tremoleda; O. Thau-Zuchman; M. Davies; J. Foster; I. Khan; K. C. Vadivelu; P. K. Yip; J. Sosabowski; W. Trigg; A. T. Michael-Titus

Pages: 1710 - 1722
The EANM practice guidelines for bone scintigraphy
Author(s): T. Wyngaert; K. Strobel; W. U. Kampen; T. Kuwert; W. Bruggen; H. K. Mohan; G. Gnanasegaran; R. Delgado-Bolton; W. A. Weber; M. Beheshti; W. Langsteger; F. Giammarile; F. M. Mottaghy; F. Paycha

Pages: 1723 - 1738
18F-FDG PET/CT in patients with idiopathic retroperitoneal and mediastinal fibrosis
Author(s): R. Fernández-López; J. A. Lojo; I. Acevedo-Báñez; R. González-León; I. Borrego-Dorado

Pages: 1739 - 1740
Severe early basal ganglia hypometabolism in neurodegeneration with brain iron accumulation
Author(s): Ismini C. Mainta; C. Tabouret-Viaud; J. Horvath; M. I. Vargas; V. Garibotto

Pages: 1741 - 1742
William T. O’Brien Sr. (Ed.), Top 3 Differentials in Neuroradiology: A Case Review. Thieme Medical Publishers, Inc., 2015. ISBN 978-1- 60406-723-1
Author(s): Davide D’Arienzo; Luigi Mansi

Pages: 1743 - 1743
Andreas Engert and Anas Younes (Eds), Hodgkin Lymphoma: A Comprehensive Overview
Author(s): Flavia Galante; Luigi Mansi

Pages: 1744 - 1745
Andrew M. Evens and Kristie A. Blum (Eds), Non-Hodgkin Lymphoma. Pathology, Imaging, and Current Therapy
Author(s): Sara Pellegrino; Luigi Mansi

Pages: 1746 - 1746
Erratum to: Dual-phase amyloid PET: hitting two birds with one stone
Author(s): Valentina Garibotto; Silvia Morbelli; Marco Pagani

Pages: 1747 - 1747

Springer

Nuclear Medicine and Molecular Imaging Gateway

Vol. 44 Number 11

Journal

Resources

Volume 43 Number 9, Aug 2016